Deciphering the detailed structure–activity relationship of coumarins as Monoamine oxidase enzyme inhibitors—An updated review VP Koyiparambath, K Prayaga Rajappan, TM Rangarajan, AG Al‐Sehemi, ... Chemical biology & drug design 98 (4), 655-673, 2021 | 41 | 2021 |
Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors ST Sudevan, JM Oh, MA Abdelgawad, MAS Abourehab, TM Rangarajan, ... Scientific reports 12 (1), 22404, 2022 | 24 | 2022 |
Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase‐B inhibitors ST Sudevan, TM Rangarajan, AG Al‐Sehemi, AS Nair, VP Koyiparambath, ... Archiv der Pharmazie 355 (8), 2200084, 2022 | 17 | 2022 |
Conjugated dienones from differently substituted cinnamaldehyde as highly potent monoamine oxidase-B inhibitors: Synthesis, biochemistry, and computational chemistry B Mathew, JM Oh, MA Abdelgawad, A Khames, MM Ghoneim, S Kumar, ... ACS omega 7 (9), 8184-8197, 2022 | 16 | 2022 |
Development of halogenated pyrazolines as selective monoamine oxidase-B Inhibitors: Deciphering via molecular dynamics approach AS Nair, JM Oh, VP Koyiparambath, S Kumar, ST Sudevan, O Soremekun, ... Molecules 26 (11), 3264, 2021 | 15 | 2021 |
KIF1A-associated neurological disorder: an overview of a rare mutational disease A Nair, A Greeny, R Rajendran, MA Abdelgawad, MM Ghoneim, ... Pharmaceuticals 16 (2), 147, 2023 | 12 | 2023 |
Navigating into the chemical space of monoamine oxidase inhibitors by artificial intelligence and cheminformatics approach S Kumar, AS Nair, V Bhashkar, ST Sudevan, VP Koyiparambath, ... ACS omega 6 (36), 23399-23411, 2021 | 12 | 2021 |
Review of β‐carboline and its derivatives as selective MAO‐A inhibitors F Benny, S Kumar, J Jayan, MA Abdelgawad, MM Ghoneim, A Kumar, ... Archiv der Pharmazie 356 (7), 2300091, 2023 | 9 | 2023 |
Discerning of isatin-based monoamine oxidase (MAO) inhibitors for neurodegenerative disorders by exploiting 2D, 3D-QSAR modelling and molecular dynamics simulation S Kumar, J Jayan, A Manoharan, F Benny, MA Abdelgawad, ... Journal of Biomolecular Structure and Dynamics 42 (5), 2328-2340, 2024 | 8 | 2024 |
Current and future nano-carrier-based approaches in the treatment of Alzheimer’s disease A Kumar, ST Sudevan, AS Nair, AK Singh, S Kumar, J Jose, T Behl, ... Brain Sciences 13 (2), 213, 2023 | 8 | 2023 |
A structural approach to investigate halogen substituted MAO-B inhibitors using QSAR modeling, molecular dynamics, and conceptual DFT analysis N Maliyakkal, I Ahmad, S Kumar, ST Sudevan, AA Beeran, H Patel, H Kim, ... Journal of Saudi Chemical Society 27 (4), 101675, 2023 | 7 | 2023 |
A concise review of the recent structural explorations of chromones as MAO-B inhibitors: Update from 2017 to 2023 RS Ipe, S Kumar, F Benny, J Jayan, A Manoharan, ST Sudevan, ... Pharmaceuticals 16 (9), 1310, 2023 | 6 | 2023 |
A review on benzimidazole scaffolds as inhibitors of Mycobacterium tuberculosis mycolyl-arabinogalactan-peptidoglycan complex biosynthesis V Bhaskar, S Kumar, AS Nair, KP Rajappan, ST Sudevan, DGT Parambi, ... Combinatorial Chemistry & High Throughput Screening 26 (4), 668-681, 2023 | 6 | 2023 |
Inhibition of monoamine oxidases by benzimidazole chalcone derivatives A Krishna, J Lee, S Kumar, ST Sudevan, P Uniyal, LK Pappachen, H Kim, ... Applied Biological Chemistry 66 (1), 37, 2023 | 5 | 2023 |
A comprehensive review of the docking studies of chalcone for the development of selective MAO-B inhibitors A Krishna, S Kumar, ST Sudevan, AK Singh, LK Pappachen, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2024 | 4 | 2024 |
Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones AK Singh, SM Kim, JM Oh, MA Abdelgawad, MM Ghoneim, ... Chemical Biology & Drug Design 102 (2), 271-284, 2023 | 4 | 2023 |
Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson’s disease: Synthesis, biochemistry, and molecular dynamics study JM Oh, S Kumar, ST Sudevan, OM Hendawy, MA Abdelgawad, A Musa, ... Computational Biology and Chemistry 105, 107899, 2023 | 3 | 2023 |
Inhibiting monoamine oxidase in CNS and CVS would be a promising approach to mitigating cardiovascular complications in neurodegenerative disorders P Srivastava, ST Sudevan, A Thennavan, B Mathew, SK Kanthlal CNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders) 23 …, 2024 | 1 | 2024 |
Flavonoid and Chalcone Scaffolds as Inhibitors of BACE1: Recent Updates AP Narayanan, J Jayan, ST Sudevan, A Dhyani, SM Zachariah, B Mathew Combinatorial Chemistry & High Throughput Screening 27 (9), 1243-1256, 2024 | | 2024 |
Enzyme Inhibition Assays for Monoamine Oxidase B Mathew, JM Oh, DGT Parambi, ST Sudevan, S Kumar, H Kim Neuroprotection: Method and Protocols, 329-336, 2024 | | 2024 |